Alzheimer's Clinical Trials Consortium (ACTC) Clinical Trials (R01 Clinical Trial Required)
Key Information
Due Date: May 7, 2024
Agency: Not Specified
Source: Federal
Funding Category:
Health & Human Services
Funding Amount: Not Specified
Funding Type: Grant
Match Required: Yes
Contact Info:
FBOWebmaster@OD.NIH.GOV
If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster
Overview
The Alzheimer's Clinical Trials Consortium (ACTC) is announcing a funding opportunity for researchers looking to develop and implement clinical trials that focus on Alzheimer's disease and other age-related dementias. This specific R01 grant is designed specifically for clinical trials that fall under Phase Ib to Phase III. The objective for these trials is to investigate potentially useful pharmacological or non-pharmacological interventions. These interventions should aim to either prevent, delay, or treat the symptoms of Alzheimer's disease. Successful applicants will have access to ACTC's trial coordination and management infrastructure in order to assist in the implementation of their clinical trials.
Show More
Key Dates
Open Date: November 24, 2020
Application Due Date: May 7, 2024
Estimated Award Date: Not Specified
Additional Details
Eligible Activities
- Research and Development
Eligible Applicants
- State governments
- County governments
- City, village or township governments
- Special district governments
- Independent school districts
- Public and State controlled institutions of higher education
- Private institutions of higher education
- Small businesses